SCHEMBL23095065

SCHEMBL23095065

c1cncc(-c2ccc(-c3ccc(-c4cc(-c5ccc6ccccc6c5)nc(-c5ccc6ccccc6c5)n4)cc3)cc2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 8/20 0.71
CYP11B1 P15538 7/20 0.71
CYP19A1 P11511 6/20 0.71
CYP17A1 P05093 4/20 0.71
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
CYP1A1 P04798 1/20 0.54
CYP1B1 Q16678 1/20 0.54
SIRT2 Q8IXJ6 1/20 0.49
CYP2A6 P11509 2/20 0.49
CYP1A2 P05177 2/20 0.49
DHODH Q02127 1/20 0.48
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 2/20 0.46
MAPT P10636 2/20 0.46
HPGD P15428 2/20 0.46
CYP3A4 P08684 1/20 0.46
STAT1 P42224 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MKNK1 Q9BUB5 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21841074 0.98 CYP11B2 (0.73) CYP11B2CYP11B1CYP19A1CYP17A1NPC1
SCHEMBL17808163 0.96 CYP11B2 (0.69) CYP11B2CYP11B1CYP19A1CYP17A1NPC1
SCHEMBL19650625 0.96 CYP11B2 (0.69) CYP11B2CYP11B1CYP19A1CYP17A1NPC1
SCHEMBL17808036 0.96 CYP11B2 (0.69) CYP11B2CYP11B1CYP19A1CYP17A1NPC1
SCHEMBL23095117 0.95 CYP11B2 (0.73) CYP11B2CYP11B1CYP19A1CYP17A1NPC1
SCHEMBL17945800 0.95 CYP11B2 (0.73) CYP11B2CYP11B1CYP19A1CYP17A1NPC1
SCHEMBL17918135 0.94 CYP11B2 (0.68) CYP11B2CYP11B1CYP19A1CYP17A1NPC1
SCHEMBL21725413 0.94 CYP11B2 (0.68) CYP11B2CYP11B1CYP19A1CYP17A1NPC1
SCHEMBL17808137 0.94 CYP11B2 (0.68) CYP11B2CYP11B1CYP19A1CYP17A1NPC1
SCHEMBL30296921 0.94 CYP11B2 (0.68) CYP11B2CYP11B1CYP19A1CYP17A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10950797-B2 Organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2021-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10950797-B2 Organic electroluminescent device SLC29A2, SLC29A1, NUDT1 CYP11B2 1102/4885CYP11B1 1493/4885CYP19A1 1301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.